These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17324648)

  • 21. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
    Leslie WD; Tsang JF; Lix LM
    Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fracture risk in perimenopausal women treated with beta-blockers.
    Rejnmark L; Vestergaard P; Kassem M; Christoffersen BR; Kolthoff N; Brixen K; Mosekilde L
    Calcif Tissue Int; 2004 Nov; 75(5):365-72. PubMed ID: 15592792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are beta-blockers useful in the prevention of osteoporotic fractures?
    Pérez-Castrillón JL; De Luis DA; Duenas-Laita A
    Eur Rev Med Pharmacol Sci; 2009; 13(3):157-62. PubMed ID: 19673165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
    Ribom EL; Ljunggren O; Mallmin H
    J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of endogenous estradiol levels on bone resorption and bone mineral density in healthy postmenopausal women: a prospective study.
    Mastaglia SR; Bagur A; Royer M; Yankelevich D; Sayegh F; Oliveri B
    Climacteric; 2009 Feb; 12(1):49-58. PubMed ID: 19003631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.
    Ruan XY; Jin FY; Liu YL; Peng ZL; Sun YG
    Chin Med J (Engl); 2008 Jul; 121(13):1155-8. PubMed ID: 18710630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes in postmenopause: different influence on bone mass according to age and disease duration.
    Hadjidakis DI; Androulakis II; Mylonakis AM; Sfakianakis ME; Raptis AE; Papaefstathiou AG; Economopoulos TC; Raptis SA
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):199-204. PubMed ID: 19085699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus.
    Safaei H; Janghorbani M; Aminorroaya A; Amini M
    Acta Diabetol; 2007 Jun; 44(2):76-82. PubMed ID: 17530471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
    Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
    Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients.
    Tsangari H; Findlay DM; Zannettino AC; Pan B; Kuliwaba JS; Fazzalari NL
    Bone; 2006 Dec; 39(6):1226-35. PubMed ID: 16926124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study.
    Levasseur R; Dargent-Molina P; Sabatier JP; Marcelli C; Bréart G
    J Am Geriatr Soc; 2005 Mar; 53(3):550-2. PubMed ID: 15743312
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease.
    Sosa M; Saavedra P; Gómez de Tejada MJ; Mosquera J; Pérez-Cano R; Olmos JM; Muñoz-Torres M; Amérigo MJ; Moro MJ; Díaz-Curiel M; Alegre J; Malouf J; Del Pino J; Nogués X; Torrijos A;
    Aging Clin Exp Res; 2011 Apr; 23(2):112-7. PubMed ID: 20463439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone tissue compositional differences in women with and without osteoporotic fracture.
    McCreadie BR; Morris MD; Chen TC; Sudhaker Rao D; Finney WF; Widjaja E; Goldstein SA
    Bone; 2006 Dec; 39(6):1190-5. PubMed ID: 16901772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise and bone mineral density at the femoral neck in postmenopausal women: a meta-analysis of controlled clinical trials with individual patient data.
    Kelley GA; Kelley KS
    Am J Obstet Gynecol; 2006 Mar; 194(3):760-7. PubMed ID: 16522410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term corticosteroid therapy induces mild changes in trabecular bone texture.
    Lespessailles E; Siroux V; Poupon S; Andriambelosoa N; Pothuaud L; Harba R; Benhamou CL
    J Bone Miner Res; 2000 Apr; 15(4):747-53. PubMed ID: 10780866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractal analysis of trabecular bone texture on calcaneus radiographs: effects of age, time since menopause and hormone replacement therapy.
    Lespessailles E; Poupon S; Niamane R; Loiseau-Peres S; Derommelaere G; Harba R; Courteix D; Benhamou CL
    Osteoporos Int; 2002 May; 13(5):366-72. PubMed ID: 12086346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients.
    Song HJ; Lee J; Kim YJ; Jung SY; Kim HJ; Choi NK; Park BJ
    Bone; 2012 Dec; 51(6):1008-15. PubMed ID: 22960238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ratio of osteocytic incorporation to bone matrix formation in femoral neck cancellous bone: an enhanced osteoblast work rate in the vicinity of hip osteoarthritis.
    Jordan GR; Loveridge N; Power J; Clarke MT; Parker M; Reeve J
    Calcif Tissue Int; 2003 Mar; 72(3):190-6. PubMed ID: 12532281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.